This finding suggests that P53 destabilization via AURKA-mediated phosphorylation, and its interaction with the P53-MDM2 axis, may differ mechanistically between HBV-HCC and Cr-HCC. This evidence concerns the gene TP53 and hepatocellular carcinoma.